Evidence map›Paper›PMID 35171665›Full record

ArticleScience advances2022

Ultrarapid lytic granule release from CTLs activates Ca

Liza Filali, Marie-Pierre Puissegur, Kevin Cortacero, Sylvain Cussat-Blanc, Roxana Khazen, Nathalie Van Acker, François-Xavier Frenois, Arnaud Abreu, Laurence Lamant, Nicolas Meyer and 4 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Cancer cells suppress NK cell activity by actin-driven polarization of inhibitory ligands to the immunological synapse.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Frontiers in immunology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Liza FilaliINSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, 31057 Toulouse, France.ORCID 0000-0003-0985-4136
Marie-Pierre PuissegurINSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, 31057 Toulouse, France.
Kevin CortaceroINSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, 31057 Toulouse, France.ORCID 0000-0003-3685-7658
Sylvain Cussat-BlancInstitut de Recherche en Informatique de Toulouse (IRIT) - University Toulouse Capitole Centre national de la recherche scientifique (CNRS) UMR5505, Artificial and Natural Intelligence Toulouse Institute, Toulouse, France.
Roxana KhazenINSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, 31057 Toulouse, France.ORCID 0000-0001-8321-9988
Nathalie Van AckerDepartment of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, 31059 Toulouse, France.ORCID 0000-0003-0420-5081
François-Xavier FrenoisDepartment of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, 31059 Toulouse, France.
Arnaud AbreuDepartment of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, 31059 Toulouse, France.ORCID 0000-0002-7838-1849
Laurence LamantDepartment of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, 31059 Toulouse, France.ORCID 0000-0002-1123-7658
Nicolas MeyerDepartment of Dermatology, Institut Universitaire du Cancer-Oncopole de Toulouse, 31059 Toulouse, France.
Béatrice VergierService de Pathologie, CHU de Bordeaux, Bordeaux, France.ORCID 0000-0002-3498-3143
Sabina MüllerINSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, 31057 Toulouse, France.ORCID 0000-0002-4580-2758
Brienne McKenzieINSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, 31057 Toulouse, France.ORCID 0000-0001-6829-9828
Salvatore ValituttiINSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, 31057 Toulouse, France.ORCID 0000-0002-6432-4421
Université Toulouse III - Paul Sabatier · FRInstitut universitaire du cancer de Toulouse Oncopole · FRCentre National de la Recherche Scientifique · FRUniversité de Bordeaux · FR

Funding

European Research Council 951329
6 · The paper itself

Abstract

Human cytotoxic T lymphocytes (CTLs) exhibit ultrarapid lytic granule secretion, but whether melanoma cells mobilize defense mechanisms with commensurate rapidity remains unknown. We used single-cell time-lapse microscopy to offer high spatiotemporal resolution analyses of subcellular events in melanoma cells upon CTL attack. Target cell perforation initiated an intracellular Ca

Indexed as

Antineoplastic AgentsMelanomaCD8-Positive T-LymphocytesCytotoxicity, ImmunologicHumansLysosomesT-Lymphocytes, CytotoxicAntineoplastic Agents

Identifiers

PMID35171665
PMCPMC8849291
OpenAlexW4212857931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.